How The Economic Downturn Has Impacted Partnering Structures, Dynamics and Dealmaking Practices

April 18, 2011

C21 BioVentures™ 2011 (C21), Trends & Issues Session:

Latham & Watkins LLP will present at C21 2011 a panel of experienced biotech and pharma dealmakers and investors comment on best partnering practices for 2011 and beyond, given the "new normal" the industry is experiencing. Topics will include defining a successful deal from all participants' viewpoints, anticipating and managing key challenges to executing partnering transactions in the current environment, and incorporating flexibility into the deal structure (using vehicles such as options to acquire the company, product rights or intellectual property rights), to allow the parties to manage their individual businesses and the collaboration in a changing environment.

Title: Partnering Trends: How The Economic Downturn Has Impacted Partnering Structures, Dynamics and Dealmaking Practices

Chair Speakers:
Ms. Judith A Hasko, Partner, Latham & Watkins LLP
Ms. Faye H Russell, Partner, Latham & Watkins LLP